Tofacitinib and TNF inhibitors demonstrated similar efficacy for managing RA at 12 months, with minor differences noted across tofacitinib treatment lines.

the T-cell inhibitor abatacept (Orencia), and the B-cell depletion agent rituximab (Rituxan), the researchers reported in ...

Early and aggressive treatment, use of methotrexate as the anchor drug and combination treatment, with older disease-modifying drugs or biologics, have become the norm. TNF inhibitors were the ...

This review will summarize the recently published or presented data on the kinase inhibitors under development for rheumatoid arthritis. Advances in treatment for rheumatoid arthritis (RA ...

And the final risk that uh we know is associated with TNF inhibitors is the risk of lymphoma. Now, again, it's a very, very small risk and it's complicated because rheumatoid arthritis itself has ...